Clinical Trial Update: Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigating whether growth hormone improves uterine receptivity in women with recurrent implantation failure undergoing oocyte donati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Implantation Failure
• Infertility

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Competence Centre on Health Technologies | Conditions: Female Infertility | EARLY_Phase 1 | Status: UNKNOWN